Latest Posts

Dr. Patrick mwamba , Belgium , WHTC hair Clinic

www.mywhtc.com











Dr. Patrick Mwamba, MD received his medical degree from the Catholic University of Louvain, Belgium in 1998. Prior to specializing in hair restoration, Dr. Mwamba participated in a fellowship in general surgery where he developed fine hands skills and learned wound management and closure techniques.

In 2000, Dr. Mwamba moved to the United States and began working with Dr. John P. Cole at New Hair Institute (NHI and MHR) in Atlanta, Georgia. Dr. Mwamba immediately fell in love with the art and science of hair replacement. His compassion for hair loss sufferers led him to dedicate his efforts, full-time, to the practice of hair transplantation.  In 2002 Dr. Mwamba went with Dr. Cole when Dr. Cole opened his own clinic - the International Hair Transplant Institute (IHTI).

In addition to working with Dr. Cole and the International Hair Transplant Institute (IHTI), Dr. Mwamba has had the pleasure of working with many other excellent physicians including Dr. Paul T. Rose, and Dr. Jean Devroye.   

Dr. Mwamba is privileged to have learned and mastered the art of total microscopic Follicular Unit Transplantation (FUT). He is also proud to be one the early developers and pioneers of the minimally invasive Follicular Isolation Technique (FIT), also known as Follicular Unit Extraction (FUE). Due to the huge demand for FIT/FUE, Dr. Mwamba’s work is largely dedicated to this elegant procedure.

Dr. Mwamba performs both STRIP and FUE.  He believes that the two techniques are complementary and what matters the most is the final results.  He believes that to better serve his patients he must master all the different techniques and aspect of hair loss.

Being in the industry for 11 years, Dr. Mwamba was trained to perform STRIP surgery at NHI, MHR, IHTI with Dr. Cole.  They were among the best because they built up their reputation on their strip cases. Because of their focus on improving their techniques to meet patient's requests, they started to develop their FUE technique called FIT in 2003.  Dr. Mwamba has 11 years of experience with STRIP and about 8 years in FUE.

In 2006, Dr. Mwamba started his own private medical practice, World Hair Transplant Center (myWHTC) in Brussels, Belgium. The practice is dedicated exclusively to hair restoration surgery and employs the finest technologies and the most cutting edge techniques. Dr. Mwamba finds his life’s work to be as challenging as it is rewarding and he constantly strives to create a joyful and productive environment for both his patients and his staff.

Dr. Mwamba is known for his kind demeanor, meticulous attention to detail, and keen aesthetic sensibility.

Studies and Presentations:

2001: Transection rate with multi-blade vs. single blade strip harvesting; Hair angulations in different regions of the scalp, International Society of Hair Restoration Surgeons (ISHRS) Annual Scientific Meeting.

2002: Stereoscopic microscope: hair transplant marketing tool or necessity for great results?; Assisting surgeons in hair transplantation, ISHRS Annual Scientific Meeting.

2005: Transection rate with Follicular Isolation Technique (FIT), European Society of Hair Restoration Surgeons (ESHRS) Annual Congress.

2006: Calculated density with Follicular Isolation Technique (FIT), ISHRS Annual Scientific Meeting.

2010: Body Hair Transplant (BHT); Different Techniques in Hair Transplant Surgery; FIT/FUE Myths, European Society of Hair Restoration Surgeons (ESHRS) Annual Congress.

2011:

Interests:
Dr. Mwamba’s interests include spending time with his family, reading the Bible, attending church, and following sports, such as basketball, American football, and golf.

Contact :
World Hair Transplant Center

73 Rue Defacqz
1060 Bruxelles
Belgium

WHTC US Office:
4840 Camberbridge Drive
Alpharetta GA 30022
USA

customer.care@mywhtc.com
+32-2-538-4404 (office)
+32 479-75-3281 (mobile)
+44-203-318-6228 (UK)
770-663-1290 (US)
Hair Transplant Surgeon: Dr. Bijan Feriduni
Hair transplant before and after results
Hair Transplant Sessions: 1
Grafts Implanted: 917
Baldness Class: NA
Surgical Procedure: Follicular Unit Extraction (FUE) 







Hair Transplant Surgeon: Dr. Patrick Mwamba
Hair transplant before and after results
Hair Transplant Sessions: 1
Grafts Implanted: 1226
Baldness Class: 2
Surgical Procedure: Follicular Unit Extraction (FUE) 









Transplant Surgeon: Dr. Raghu Reddy
Hair transplantation surgical procedure before and after results
Hair Transplant Sessions: 1
Grafts Implanted: 1207 (Total Hair 4100)
Baldness Class: 2
Surgical Procedure: Follicular Unit Extraction (FUE) 




Surgeon: Dr. Raghu Reddy

Hair restoration surgery before after results
Hair Transplant Sessions: 1
Grafts Implanted: 1306
Baldness Class: 4A
Surgical Procedure: Follicular Unit Extraction (FUE) 





Transplant Surgeon: Bijan Feriduni
Hair restoration surgical procedure before after results
Transplant Sessions: 1
Grafts Implanted: 2308
Baldness Class: 3
Surgical Procedure: Follicular Unit Extraction (FUE) 





Transplant Surgeon: Dr. Kyriacos Maras

Hair restoration transplant before after results
Transplant Sessions: 1
Grafts: 3050
Baldness Class: 3
Surgical Procedure: Follicular Unit Extraction (FUE) 







Surgeon: Dr. Steven Gabel
Grafts : 350
Female Hair Transplant
Surgical Procedure: Follicular Unit Transplant (FUT/Strip) 


 

Histogen Announces Initial Close of Series A Financing Round

  
SAN DIEGO, May 2, 2008 - Histogen, Inc., a regenerative medicine company developing solutions based on the products of newborn fibroblasts, today announced the initial close of Series A financing at $5.35 million. The round was completed by private and corporate investors, including Secure Medical Inc., CellCeuticals Skin Care Inc., and Leonard H. Lavin, founder and Chairman Emeritus of the Alberto-Culver Company.
Histogen will utilize the round to fund Phase 1 clinical trials for hair growth and complete 510k submissions for wound and hernia repair applications. The round will also enable the Company to upscale manufacturing for Exceltrix, Histogen's human Extracellular Matrix product, and HGEN-001, Histogen's proprietary liquid formulation.
"We are pleased that we have exceeded our original target for the Series A round, and have added highly experienced investors to our list of shareholders," said Gail K. Naughton, Ph.D., CEO of Histogen. "With the close of this financing, we look forward to bringing additional talent to our already seasoned team, and getting our first products to market within the next 12 months."
The initial close of Series A financing will allow Histogen to maintain timelines for product introductions, including the Company's first tissue engineering products, which are slated for launch in late 2008 and early 2009. From two product families, Exceltrix and HGEN-001, which are derived from a single manufacturing process, Histogen forsees a breadth of applications in a variety of markets, from research tools to cosmeceuticals.
About Histogen
Histogen, launched in 2007, seeks to redefine regenerative medicine by developing a series of high value products without the use of embryonic stem cells or animal products. Through Histogen's proprietary bioreactors that mimic the embryonic environment, newborn fibroblasts are encouraged to naturally produce the vital proteins and growth factors from which the company has developed its rich product portfolio. Histogen has two product families - Exceltrix, Histogen's human Extracellular Matrix (ECM) and HGEN-001, Histogen's proprietary liquid formula.